Reduced background autofluorescence for cell imaging using nanodiamonds and lanthanide chelates
At a Glance
Section titled “At a Glance”| Metadata | Details |
|---|---|
| Publication Date | 2018-03-08 |
| Journal | Scientific Reports |
| Authors | Nicole M. Cordina, Nima Sayyadi, Lindsay M. Parker, Arun Everest‐Dass, Louise J. Brown |
| Institutions | Macquarie University, Griffith University |
| Citations | 65 |
| Analysis | Full AI Review Included |
Executive Summary
Section titled “Executive Summary”- Core Challenge Addressed: Cellular autofluorescence (450-670 nm) interferes with conventional fluorophore detection in bio-imaging, particularly in highly autofluorescent cells like brain endothelial tissue.
- Nanodiamond Approach (NV Centers): Fluorescent nanodiamonds (FNDs) containing nitrogen-vacancy (NV) centers emit at ~700 nm, bypassing background autofluorescence via spectral separation.
- Key Performance Finding: 30 nm FNDs coated with an E-selectin antibody achieved a 40-fold increase in signal intensity (AU 16.0 ± 8.8 vs. 0.4 ± 0.5) in TNFα-induced versus uninduced cells.
- Lanthanide Alternative: Europium-chelating tags (BHHTEGST-Eu) leverage long luminescent lifetimes for time-gated imaging, achieving a 5.4× signal ratio between induced and uninduced cells when paired with multivalent SLeX-PAA-biotin.
- Particle Size Principle: Despite 100 nm FNDs containing ~500 NV centers (~170× brighter per particle), the 30 nm particles demonstrated superior intracellular penetration and target specificity, illustrating that “bigger is not always better.”
- Versatile Scaffold: A PEGylated streptavidin-biotin platform (FND-PEG-SA) enables universal attachment of any biotinylated ligand, allowing rapid adaptation to new biomolecular targets.
- Functionalization Tolerance: Carboxylated FND surfaces (-COOH) accept standard EDC/NHS carbodiimide chemistry, enabling covalent PEG22 spacer arm attachment and downstream protein conjugation.
Technical Specifications
Section titled “Technical Specifications”| Parameter | Value | Unit | Context |
|---|---|---|---|
| FND Type | Type Ib synthetic diamond powder | — | Source material (Adamas Nano, Academia Sinica) |
| FND Sizes Tested | 30, 100 | nm | Two particle sizes compared |
| NV Centers (30 nm FND) | 1-3 | per particle | Low NV loading due to volume constraints |
| NV Centers (100 nm FND) | ~500 | per particle | High NV loading, ~170× brighter than 30 nm |
| NV Excitation Wavelength | 555 ± 12.5 | nm | ET555/25× Chroma filter |
| NV Emission Maxima | ~700 | nm | Above cellular autofluorescence range (450-670 nm) |
| NV Dichroic Cutoff | 635 | nm | T635lpxr Chroma |
| Emission Bandwidth | 700 ± 37.5 | nm | ET700/75m Chroma collection filter |
| FND Surface Chemistry | Carboxylated (-COOH) | — | Starting functional group for EDC/NHS coupling |
| Zeta Potential (30 nm FND-COOH) | -40.4 ± 22.8 | mV | Monodispersed colloidal stability |
| Zeta Potential (100 nm FND-COOH) | -34.3 ± 7.0 | mV | Monodispersed colloidal stability |
| Zeta Potential Threshold | > |30| | mV | Required for colloidal dispersion stability |
| DLS Size (30 nm FND-COOH) | 36.42 ± 8.96 | nm | Number-weighted distribution |
| DLS Size (30 nm FND-PEG22) | 52.55 ± 17.62 | nm | +16.1 nm after PEGylation |
| DLS Size (30 nm FND-PEG22-SA) | 59.14 ± 17.85 | nm | +6.6 nm after SA conjugation |
| DLS Size (100 nm FND-PEG22-SA) | 149.3 ± 25.6 | nm | After full functionalization |
| PEG22 Spacer Length | 8-9 | nm | Extended conformation size |
| Streptavidin Dimension | ~5 | nm | Largest axis (PDB 3WYP) |
| EDC Concentration (activation) | 3.2 | mg | Per 0.8 mg FND batch |
| NHS Concentration (activation) | 4.8 | mg | Per 0.8 mg FND batch |
| EDC/NHS Reaction pH | 4 | — | Acidic conditions for carboxyl activation |
| PEG Conjugation pH | 8 | — | Basic DDW for amine coupling |
| DTT Quench Concentration | 50 | mM | Final concentration to inactivate EDC |
| PEG22 (CA(PEG)22) Mass | 4 | mg | Per 0.8 mg FND batch |
| PEG Reaction Time | 3 + 16 | hrs | 3 hrs RT + 16 hrs at 4°C |
| Ethanolamine Quench | 50 | mM | Blocks remaining NHS esters |
| Streptavidin Conjugation Mass | 100 | µg | Per batch |
| Final FND-PEG-SA Concentration | 2 | mg/mL | Resuspended in neutral DDW |
| SA-BHHTEGST-Eu Working Conc. | 0.2 | mg/mL | For cell staining |
| BHHTEGST Molar Excess | 30-fold (max) | — | Beyond 30-fold causes precipitation |
| BHHTEGST:SA Final Ratio | 18:1 | mol/mol | SA-BHHTEGST18 achieved |
| BHHTEGST ε335 | 3.14 × 104 | M-1cm-1 | Molar extinction at 335 nm |
| BHHTEGST ε280 | 1.75 × 104 | M-1cm-1 | Molar extinction at 280 nm |
| Centrifugation Force | 16,000 × g | — | For FND pelleting |
| Centrifugation Time | 25 | mins | Per wash cycle |
| DLS Laser Source | 633 | nm | Malvern Zetasizer Nano ZS |
| Imaging Objective | 40× / 1.6 NA | — | Dry objective, Olympus BX63 |
| Imaging Exposure (NV channel) | 14 | s | Constant across all samples |
| TGL Exposure (Eu channel) | 5.0 | s | ASA 200, DP72 color camera |
| FND Conc. Standard Slope | 2242.9 | AU·mL/µg | Emission at 678 nm vs. 530 nm excitation |
| TNFα Induction Dose | 20 | ng/mL | Cytokine for E-selectin upregulation |
| TNFα Induction Time | 4 | hrs | Optimal expression window |
| Cell Seeding Density | 104 | cells/cm2 | bEnd.3 mouse brain endothelial cells |
| Fixative | 4% PFA | v/v | 15 min fixation, non-permeabilized |
| Blocking Agent | Normal horse serum | 100 µL/mL | 30 min for antibody experiments |
| Best Signal Ratio (30 nm FND-PEG-Ab) | 40× | fold | TNFα vs. uninduced |
| Best Eu Signal Ratio (multivalent SLeX) | 5.4× | fold | TNFα vs. uninduced |
| Background Noise (30 nm FND) | 0.04 | AU | Negligible autofluorescence |
| Background Noise (100 nm FND) | 0.10 | AU | Negligible autofluorescence |
| Background Noise (Eu chelate) | 1.28 | AU | Slightly elevated baseline |
| Polydispersity Index | < 0.3 | — | Indicates monodispersity |
Key Methodologies
Section titled “Key Methodologies”- Step 1 - Carboxylated FND Activation: Suspend 0.8 mg FND in acidic DDW (pH 4); incubate with 3.2 mg EDC and 4.8 mg NHS for 20 min at room temperature to activate -COOH groups.
- Step 2 - EDC Quenching: Add DTT to a final concentration of 50 mM to inactivate excess EDC.
- Step 3 - PEG22 Coupling: Pellet FND-NHS by centrifugation (16,000 × g, 25 min); resuspend in basic DDW (pH 8); add 4 mg CA(PEG)22 amino-PEG; agitate at 3,000 rpm for 3 hrs at RT, then 16 hrs at 4°C.
- Step 4 - Quench Unreacted NHS: Add ethanolamine to 50 mM; incubate 2 hrs to cap residual NHS esters.
- Step 5 - Streptavidin Conjugation: Reactivate terminal PEG carboxyls with EDC/NHS; couple 100 µg recombinant streptavidin at pH 8 for 3 hrs (3,000 rpm) + 16 hrs at 4°C.
- Step 6 - Final Wash and Resuspension: Wash pellet by centrifugation (16,000 × g, 25 min); resuspend FND-PEG-SA in neutral DDW (pH 7) at 2 mg/mL.
- Step 7 - Ligand Loading: Incubate 100 µL FND-PEG-SA (0.5 mg/mL) with 10 µL biotinylated SLeX (0.1 mg/mL) in PBS-BSA for 1 hr at 3,000 rpm.
- Step 8 - Europium Alternative Scaffold: Mix 100 µg streptavidin in 100 mM NaHCO3 (pH 8.5) with 20-fold molar excess BHHTEGST; incubate 1 hr at 37°C; purify on Sephadex G-25 PD MiniTrap.
- Step 9 - Cell Induction and Staining: Induce E-selectin in bEnd.3 cells with 20 ng/mL TNFα for 4 hrs; fix with 4% PFA for 15 min; incubate with 5 µL of 0.5 mg/mL probe for 2 hrs at 37°C.
- Step 10 - Imaging Acquisition: Capture NV emission at 555 nm ex / 700 nm em with 14 s exposure; for Eu, use time-gated luminescence (5 s exposure) on Olympus BX51/BX63 platforms.
6CCVD Solutions & Capabilities
Section titled “6CCVD Solutions & Capabilities”-
Applicable Materials:
- This research utilized 30 nm and 100 nm Type Ib fluorescent nanodiamonds (FNDs) containing nitrogen-vacancy (NV) centers. For replication or scale-up of similar bio-imaging probes, 6CCVD supplies Optical Grade Single Crystal Diamond (SCD) and Polycrystalline Diamond (PCD) substrates that can be processed into nanodiamond feedstocks or used as bulk optical references.
- The carboxylated surface chemistry required in this paper aligns with 6CCVD’s standard -COOH terminated diamond surfaces, ready for downstream EDC/NHS functionalization.
-
Customization Potential:
- While this paper used standard 30 nm and 100 nm particle batches, 6CCVD offers custom diamond substrate dimensions up to 125 mm (PCD) with thickness ranges from 0.1 µm to 500 µm for SCD/PCD, ideal for fabricating specialized diamond platforms or wafer-scale NV center arrays.
- Researchers requiring custom metallization for device integration (e.g., Ti/Pt/Au contact pads for in-situ electrical or plasmonic enhancement of NV emission) can leverage 6CCVD’s in-house metallization capabilities (Au, Pt, Pd, Ti, W, Cu).
- For applications requiring precise particle morphology or thin-film formats, 6CCVD provides laser cutting services to dimension diamond substrates to exact specifications.
-
Engineering Support:
- 6CCVD’s in-house PhD engineering team can assist with material selection for advanced biomedical imaging, quantum sensing, and NV-center based diagnostic platforms, including guidance on optimizing surface termination (carboxylated, hydrogen-terminated, or oxygen-terminated) for bioconjugation workflows.
- For projects requiring ultra-smooth optical interfaces, 6CCVD’s polishing services achieve Ra < 1 nm (SCD) and < 5 nm (inch-size PCD), critical for minimizing scattering losses in fluorescence collection paths.
- Whether scaling up from nanodiamond suspensions to bulk diamond sensors, or developing next-generation quantum-biological hybrid devices, 6CCVD provides consultative support across the full MPCVD material lifecycle.
-
Call to Action:
- For custom specifications or material consultation, visit 6ccvd.com or contact our engineering team directly.
View Original Abstract
Bio-imaging is a key technique in tracking and monitoring important biological processes and fundamental biomolecular interactions, however the interference of background autofluorescence with targeted fluorophores is problematic for many bio-imaging applications. This study reports on two novel methods for reducing interference with cellular autofluorescence for bio-imaging. The first method uses fluorescent nanodiamonds (FNDs), containing nitrogen vacancy centers. FNDs emit at near-infrared wavelengths typically higher than most cellular autofluorescence; and when appropriately functionalized, can be used for background-free imaging of targeted biomolecules. The second method uses europium-chelating tags with long fluorescence lifetimes. These europium-chelating tags enhance background-free imaging due to the short fluorescent lifetimes of cellular autofluorescence. In this study, we used both methods to target E-selectin, a transmembrane glycoprotein that is activated by inflammation, to demonstrate background-free fluorescent staining in fixed endothelial cells. Our findings indicate that both FND and Europium based staining can improve fluorescent bio-imaging capabilities by reducing competition with cellular autofluorescence. 30 nm nanodiamonds coated with the E-selectin antibody was found to enable the most sensitive detective of E-selectin in inflamed cells, with a 40-fold increase in intensity detected.